Current status adalimumab treatment of Crohn's disease in children

Abstract

Adalimumab (ADA) is a fully human IgG antibody against TNF-alpha. Its efficacy and safety data demonstrated in clinical studies, particularly randomized controlled trials IMAgINE.

Keywords

• adalimumab
• Crohn's disease